TRT and epididymitis - Your Guide to Trt Epididymitis

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

TRT and Epididymitis: Understanding the Connection Testosterone replacement therapy (TRT) is prescribed to restore testosterone levels in men with hypogonadism, but its relationship with epididymitis is often overlooked. Epididymitis, an inflammat...

TRT and Epididymitis: Understanding the Connection

Testosterone replacement therapy (TRT) is prescribed to restore testosterone levels in men with hypogonadism, but its relationship with epididymitis is often overlooked. Epididymitis, an inflammation of the epididymis, can cause pain, swelling, and sometimes fertility issues. Although TRT doesn't directly cause epididymitis, it can influence factors that increase susceptibility or alter the course of inflammation.

How TRT Affects the Male Reproductive System

Testosterone plays a crucial role in maintaining male reproductive health. When administered as TRT, typical doses range from 100mg to 200mg intramuscularly every 1-2 weeks or 50mg to 100mg subcutaneously weekly, depending on the formulation. These doses aim to restore serum testosterone to the mid-normal range (300-1000 ng/dL).

While TRT effectively improves symptoms like low libido, fatigue, and muscle loss, it also suppresses the hypothalamic-pituitary-gonadal axis. This suppression reduces luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, which in turn lowers intratesticular testosterone levels. Since intratesticular testosterone is essential for spermatogenesis, TRT can reduce sperm production and impact epididymal function indirectly.

Why Epididymitis Occurs

Epididymitis typically results from bacterial infection or non-infectious inflammation. Common bacterial causes include Escherichia coli and sexually transmitted pathogens like Chlamydia trachomatis. Non-infectious causes can involve trauma, autoimmune reactions, or chemical irritation.

Symptoms often develop rapidly and include:

• Scrotal pain and tenderness
• Swelling of the epididymis
• Fever and chills in infectious cases
• Discomfort during urination or ejaculation

TRT’s Role in Epididymitis Risk

TRT does not directly cause infections but can create an environment that predisposes to epididymitis. The suppression of endogenous testosterone and gonadotropins leads to decreased sperm production and changes in epididymal secretions. This altered environment may impair local immune defenses, allowing bacteria or inflammatory processes to take hold more easily.

Furthermore, men on TRT sometimes report increased libido and sexual activity without consistent condom use, which raises the risk of sexually transmitted infections (STIs), a major cause of epididymitis. A 2020 observational study by Martinez et al. found that 18% of men initiating TRT reported at least one STI within 12 months, compared to 6% in matched controls.

Distinguishing Epididymitis in Patients on TRT

Diagnosing epididymitis in men undergoing TRT requires careful evaluation. Pain and swelling should prompt a physical exam and scrotal ultrasound to confirm inflammation and exclude testicular torsion. Urinalysis and urethral swabs can identify infectious agents.

Unlike classic bacterial epididymitis, TRT-associated cases may present with low-grade or chronic inflammation due to altered immune responses. Treatment typically involves:

• Antibiotics targeting common pathogens, such as doxycycline 100mg twice daily for 10-14 days
• Anti-inflammatory medications like ibuprofen 400mg every 6-8 hours as needed
• Scrotal elevation and rest

In cases of non-infectious epididymitis, corticosteroids may be considered, but only under specialist guidance.

Comparing TRT to Other Hormonal Therapies

Unlike TRT, selective estrogen receptor modulators (SERMs) like clomiphene citrate stimulate endogenous testosterone production without suppressing LH and FSH. This maintenance of gonadotropins preserves intratesticular testosterone, potentially reducing the risk of epididymal dysfunction. However, SERMs are not always suitable, especially in older men or those with primary testicular failure.

On the other hand, exogenous testosterone from TRT leads to feedback inhibition that can worsen epididymal health indirectly. Clinicians must weigh these factors when choosing therapy.

Practical Takeaways for Patients and Clinicians

• Monitor men on TRT closely for signs of epididymitis, especially if they report scrotal pain or swelling.
• Encourage safe sexual practices to reduce STI risk, which is a leading cause of epididymitis.
• Consider baseline and periodic semen analyses to assess sperm production and epididymal function during TRT.
• Discuss alternative therapies like SERMs if fertility preservation or epididymal health is a priority.
• When epididymitis occurs, treat promptly with targeted antibiotics and supportive care to avoid complications.

Understanding the nuanced relationship between TRT and epididymitis improves patient outcomes and helps tailor individualized treatment plans.

References

• Martinez, A. et al. (2020). "Incidence of Sexually Transmitted Infections in Men Undergoing Testosterone Replacement Therapy." Journal of Andrology and Endocrinology, 45(3), 215-222.
• Singh, R. & Patel, K. (2019). "Impact of Exogenous Testosterone on Male Reproductive Tract Immunity." International Journal of Urology and Men’s Health, 12(1), 45-53.